Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia

Schizophrenia is a complex psychiatric disorder strongly associated with substance use disorders. Theoretically, schizophrenia and SUD may share endocannabinoid alterations in the brain reward system. The main endocannabinoids, anandamide, and 2-arachidonoylglycerol, are lipids which bind cannabinoi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Desfossés, Joëlle, Stip, Emmanuel, Bentaleb, Lahcen Ait, Lipp, Olivier, Chiasson, Jean-Pierre, Furtos, Alexandra, Venne, Karine, Kouassi, Edouard, Potvin, Stéphane
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Research Foundation 2012
Materias:
Psychiatry
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
https://ncbi.nlm.nih.gov/pubmed/23055987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2012.00085
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares